The Scientific Committee of the ETS Diabetes Research Foundation is responsible for formulating and implementing research programs, as well as preparing training and awareness-raising activities.

BARBARA HANSEN

She has held prestigious positions at the National Institute of Health in Bethesda (USA). She is currently a Full Professor of Internal Medicine at the University of South Florida, Tampa, USA. The world’s leading expert on Metabolic Syndrome and Type 2 Diabetes Mellitus.

Dr. Barbara Hansen is the Director of the Obesity, Diabetes and Aging Research Center of the Morsani College of Medicine and Professor of Internal Medicine and Pediatrics at the University of South Florida, Tampa. Her research has addressed the physiological, cellular, and molecular defects underlying the development of obesity, metabolic syndrome, and diabetes mellitus and their prevention. She has over 200 publications.

https://awards.research.usf.edu/profiles/?id=210

DANIEL PIPELEERS

Emeritus Professor at the Free University of Brussels.

The leading European expert on Type 1 Diabetes cellular therapy. Representative of the European Union for this treatment (EuroStemCell).”

Between 1971 and 1980, investigator Belgian Research Foundation and Harkness Fellow Commonwealth Foundation at Université Libre de Bruxelles, Washington University St Louis, Queen Elisabeth Foundation Brussels. Since 1980, professor at Vrije Universiteit Brussel-VUB and since 1987 consultant at University Hospital, Brussels. Since 1990, director VUB-Diabetes Research Center where expertise in beta cell biology, pathology and therapy guides strategies and trials for early diagnosis, prevention and treatment of type 1 diabetes. Founder of cell therapy company Beta-Cell nv, and two networks for clinical translation, the Belgian Diabetes Registry with associated Diabetes Biobank, and the Consortium for Beta Cell Therapy in Diabetes. Since 2002 director of international Beta Cell Therapy program, supported by European Union and Juvenile Diabetes Research Foundation. He is Honorary Doctor at Uppsala University, Sweden, member of the Belgian Royal Academy of Medicine, recipient of twelve (inter)national awards in medical sciences. He serve(s)(d) as board member and advisor in academic, clinical and governmental institutions, in scientific and bioindustrial organizations.

https://www.beta-cell.com/keypeople/daniel-pipeleers/

PAOLO POZZILLI

Emeritus Professor at the University of Rome La Sapienza.

One of the foremost figures in international research on Type 1 Diabetes immunotherapy.

Author of hundreds of publications and editor of high-impact international scientific journals.

Additionally, he is a Full Professor of Endocrinology and Metabolic Diseases, Director of the Endocrinology Area at the Campus Bio-Medico University of Rome, where he is also responsible for the Endocrinology and Diabetology Residency Program and the International PhD Program in Endocrinology and Metabolic Diseases. He is a Diabetes Research Professor at St. Bartholomew’s and the London School of Medicine, Queen Mary, University of London. He has published 395 works on both Type 1 and Type 2 diabetes, diabetes complications, new routes of insulin administration, and autoimmune thyroid diseases.

https://www.unicampus.it/it/persone/4158

ANTONINO DE LORENZO

Full Professor of Human Nutrition Science and Director of the Department of Clinical and Preventive Biomedicine at the University of Rome “Tor Vergata”. National Coordinator of Clinical Human Nutrition. Author of over 200 publications.

He is a member of the Italian Society of Alcology, Italian Society of Gastroenterology, Italian Society of Physiology, Italian Society of Human Nutrition (member of the board since 2000), The American Society of Clinical Nutrition, The American Physiological Society, Italian Union Against Obesity (UICO), New York Academy of Sciences (NY-USA), President of the International Center for Body Composition of the University of Milan, President of the National Institute for the Mediterranean Diet and Nutrigenomics.

https://www.unipa.it/amministrazione/arearisorseumane/settorereclutamentoeselezioni/.content/2020/cv-comm/cv_de_lorenzo.pdf

http://www.aracneeditrice.it/aracneweb/index.php/autori.html?auth-id=ADLrm2n

PIERO MARCHETTI

Full Professor of Endocrinology, University of Pisa.

Director of the Complex Operative Unit of Metabolism and Diabetology, University and Hospital Company “Cisanello” of Pisa.

One of the most renowned international scholars in the cellular and molecular pathophysiology of pancreatic beta cells and their role in the development of type 1 and type 2 diabetes mellitus.

FEDERICO ROSSI

Full Professor of Materials Engineering, Department of Engineering, University of Perugia.

Author of important international articles on biomaterials for human applications.

https://www.unipg.it/personale/federico.rossi/cv

PAOLO BLASI

Associate Professor of Pharmaceutical Sciences and Techniques, Faculty of Pharmacy, University of Bologna.

Teacher in Nanoformulations of Biological, Advanced Pharmaceutical Technology and Medical Devices.

Teacher in disciplines related to Advanced Pharmaceutical Technology.

International researcher of biopolymers for human cellular therapies.

https://www.unibo.it/sitoweb/p.blasi

CARMINE G. FANELLI

Associate Professor of the MISEM Complex Structure, Department of Medicine and Surgery, University of Perugia.

Director of the School of Specialization in Food Sciences.

Responsible for the CURIAMO Center.

He spent several years as a researcher in the USA on type 1 diabetes mellitus.

https://www.unipg.it/personale/carmine.fanelli

GIUSEPPE NOCENTINI

Associate Professor of Pharmacology, Department of Medicine and Surgery, University of Perugia.

International expert in Immunopharmacology, with prestigious international research and related scientific publications.

https://www.unipg.it/personale/giuseppe.nocentini

FEDERICO BERTUZZI

Director of the Complex Operative Unit of Diabetology, Niguarda Hospital in Milan.

One of the current international leaders in pancreatic cell transplantation for the radical treatment of type 1 diabetes mellitus.

Scroll to Top